Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02111681 · ClinicalTrials.gov registry record · NA

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT02111681: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02111681 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02111681, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The purpose of this study is to test the use of Calypso beacon implants as a way to determine where the lung tumor is located during radiation treatment. The Calypso beacons are small devices that are implanted in the lungs, near the tumor. They are able to send a signal to a tracking system to show where they are, and where the tumor is, as the patient holds their breath for the radiation treatment. The investigators want to find out what effects, good and/or bad, that this has on the patient and the way they treat the cancer in your lungs.

Primary Outcome

Feasibility is defined as completion of all treatments using the DIBH treatment plan and Calypso transponders.

Interventions

  • DEVICE Calypso Beacon Implantation

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2014-04
Est. Completion 2024-07-01
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02111681 record still lists

NCT02111681 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Calypso Beacon Implantation is the first listed.

NCT02111681 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02111681 about?

NCT02111681 is a clinical study titled "Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer". The purpose of this study is to test the use of Calypso beacon implants as a way to determine where the lung tumor is located during radiation treatment. The Calypso beacons are small devices that are implanted in the lungs, near the tumor. They are able to send a signal to a tracking system to show...

What is the current status of trial NCT02111681?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2014-04. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT02111681?

The interventions under investigation include: Calypso Beacon Implantation (DEVICE).

Who is sponsoring clinical trial NCT02111681?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02111681's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02111681, the US trial registry maintained by the National Library of Medicine. NCT02111681 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.